Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Livzon Mabpharm Inc.

Division of Livzon Pharmaceutical Group Inc.
www.livzon.com.cn

Latest From Livzon Mabpharm Inc.

Deal Watch: Focus Placed On Psoriasis With Recent Purdue, Sienna Deals

Purdue will partner with Exicure to develop psoriasis therapies using the latter’s Spherical Nucleic Acid platform, while Sienna buys Creabilis to advance its psoriasis candidate to Phase III. Meanwhile, one focus of the Almirall/Nuevolution tie-up will be psoriatic arthritis.

Deals M & A

Deals Shaping The Medical Industry, October 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.

BioPharmaceutical Medical Device

Epirus Strikes Biosimilars Deal With China’s Livzon

Boston-based Epirus Biopharmaceuticals has made its second recent advance in the Asian region, this time with a broad-based deal for antibody-based drugs with its investor and Chinese biotech, Livzon Mabpharm.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Livzon Pharmaceutical Group Inc.
  • Senior Management
  • Tao Desheng, CEO
    Wu Wenqi, VP, R&D
    Xu Guoxiang, VP, Sales
  • Contact Info
  • Livzon Mabpharm Inc.
    Phone: 756-8135859
    132 Guihua Rd. North
    Zhuhai, 519020
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register